High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC)
Bettina Sonnweber(Innsbruck Medical University), Wolfgang Hilbe(Otto Wagner Hospital)
Cited by 39
Related Papers
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper
|Oncology Research and Treatment|2020|88